Barbital

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Fuzzform (talk | contribs) at 02:00, 5 March 2006. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Jump to navigation Jump to search
Barbital
Clinical data
Pregnancy
category
  • ?
Routes of
administration
Oral
ATC code
Legal status
Legal status
  • ?
Pharmacokinetic data
Bioavailability?
Metabolism?
Elimination half-life?
Excretion?
Identifiers
  • 5,5-diethyl-1,3-diazinane-2,4,6-trione
PubChem CID
DrugBank
CompTox Dashboard (EPA)
ECHA InfoCard100.000.301 Edit this at Wikidata
Chemical and physical data
FormulaC8H12N2O3
Molar mass184.193

Barbital (marketed under the brand name Veronal), also called barbitone, was the first commercially marketed barbiturate. It was used as a sleeping aid (hypnotic) from 1903 until the mid-1930s. The chemical names for barbital are diethylmalonyl urea or diethylbarbituric acid. Its chemical formula is (C2H5)2C~CO NH]ICO (sodium 5,5-diethyl barbiturate). Veronal was prepared by condensing diethylmalonic ester with urea in the presence of sodium ethylate, or by adding ethyl iodide to the silver salt of malonylurea. The result was an odorless, slightly bitter, white crystalline powder.

Barbital was first synthesized in 1902 by German chemists Emil Fischer and Joseph von Mering. They published their discovery in 1903 and it was marketed in 1904 by the Bayer company as “Veronal”. A soluble salt of barbital was marketed by the Schering company as “Medinal.” It was dispensed for “insomnia induced by nervous excitability”. [1] It was provided in either capsules or cachets. The therapeutic dose was ten to fifteen grains.

Veronal was considered to be a great improvement over the existing hypnotics. Its taste was slightly bitter, but an improvement over the strong, unpleasant taste of the commonly used bromides. It had few side effects. Its therapeutic dose was far below the toxic dose. However, prolonged usage resulted in tolerance to the drug, requiring higher doses to reach the desired effect. Fatal overdoses of this slow acting hypnotic were not uncommon.

References

  • Fischer, Emil and Joseph von Mering, “Ueber eine neue Klasse von Schlafmitteln”, Therap Gegenw 44:97-101, 1903.
  • "Veronal", in Finley, Ellingwood, M.D. The American Materia Medica, Therapeutics and Pharmacognosy", 1919. [2], accessed 07 Nov 2005.


Public Domain This article incorporates text from a publication now in the public domainChisholm, Hugh, ed. (1911). Encyclopædia Britannica (11th ed.). Cambridge University Press. {{cite encyclopedia}}: Missing or empty |title= (help)